Department of Surgery, Hachioji Digestive Disease Hospital, 177-3 Yorozu-cho, Hachioji, Tokyo 192-0903, Japan.
J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):258-62. doi: 10.1007/s00534-010-0339-4.
BACKGROUND/PURPOSE: The aim of this study was to evaluate the long-term complications of pancreaticoduodenectomy with a duct-to-mucosa pancreaticojejunostomy anastomosis without a stenting tube.
Patients were followed for at least 3 years after pancreaticoduodenectomy. They were classified into two groups: duct-to-mucosa pancreaticojejunostomy anastomosis with a stenting tube (group A: 24) and without a stenting tube (group B: 21). Outcomes, including complications and dilatation of the pancreatic duct, were reported retrospectively.
The following complication rates were found for group A: morbidity 29.1%, cholangitis 12.5%, nonalcoholic steatohepatitis 4.2%, liver abscess 4.2%, intrahepatic stones 4.2%, abnormal glucose tolerance (progression of diabetes) 20.8%, and dilatation of the pancreatic duct 20.8%. In group B, the rates for morbidity (14.3%) and abnormal glucose tolerance (19%), and dilatation of the pancreatic duct (4.8%) were lower than those in group A, but all results lacked statistical significance.
Pancreaticoduodenectomy with a duct-to-mucosa anastomosis of pancreaticojejunostomy with or without a stenting tube showed no difference in long-term follow-up.
背景/目的：本研究旨在评估不使用支架管进行黏膜吻合胰肠吻合的胰十二指肠切除术的长期并发症。
对接受胰十二指肠切除术的患者进行了至少 3 年的随访。他们被分为两组：使用支架管的胰肠吻合黏膜吻合术（A 组：24 例）和不使用支架管的胰肠吻合黏膜吻合术（B 组：21 例）。回顾性报告了包括并发症和胰管扩张在内的结果。
A 组的并发症发生率如下：发病率 29.1%、胆管炎 12.5%、非酒精性脂肪性肝炎 4.2%、肝脓肿 4.2%、肝内结石 4.2%、异常葡萄糖耐量（糖尿病进展）20.8%和胰管扩张 20.8%。B 组的发病率（14.3%）和异常葡萄糖耐量（19%）以及胰管扩张（4.8%）的发生率低于 A 组，但所有结果均无统计学意义。
带或不带支架管的胰肠吻合黏膜吻合胰十二指肠切除术在长期随访中无差异。
